
PT-141 (Bremelanotide) - 10mg
The first peptide in its class with regulatory approval. A centrally-acting MC4-preferential melanocortin agonist with approval for HSDD under the trade name Vyleesi. Research use only.
Description
The first peptide in its class to win regulatory approval — PT-141 (bremelanotide) has a clinical pedigree that few research peptides can match. As a centrally-acting melanocortin agonist, it brought an entirely new mechanism to sexual response research, distinct from the peripheral vascular pathways targeted by the established small-molecule alternatives.



PT-141 (Bremelanotide) - 10mg
Peptides can affect the way the body functions at a cellular level.
some peptides may help speed recovery from musculoskeletal injuries like fractures and torn ligaments
Can We Slow the Aging Process?
peptides are highly targeted cellular scalpels. They mimic the body's exact signalling language to toggle specific cellular switches on or off.
Using Artificial Intelligence to map out new synthetic peptides opens the door for personalised recovery.
Like protein, peptides can do anything and everything in the body.
Exosomes are skin care gold for brands looking to market innovation,

Our 3 Step System
Pre-filled CartridgesEngineered for absolute accuracy and ease. Our pre-blended pens make precise dosing completely seamless in just three quick steps.
Step 1 - Remove the Pre-mixed pen from the box
Step 2 - Secure the needle tip
Step 3 - Twist to set the required dose

Engineered Precision vs. Manual Reconstruction
Our pre-blended, calibrated pens compress a tedious multi-step laboratory chore into a seamless, tactile three-step workflow built for absolute precision and zero waste.




